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PROFIL PENGEKSPRESAN GEN DARI FIBROBLAS UTAMA KELOID DAN 
KULIT NORMAL YANG DIRAWAT MENGGUNAKAN PECAHAN 
TOKOTRIENOL (TRF) MINYAK KELAPA SAWIT  
 
ABSTRAK 
 
Keloid adalah penyakit kulit fibroproliferatif yang terbentuk disebabkan oleh tindak 
balas luka yang tidak normal pada individu tertentu. Perubahan terhadap faktor 
pertumbuhan dan sitokin dalam proses penyembuhan yang tidak normal membentuk 
keadaan yang tidak seimbang antara sintesis dan degradasi kolagen dan komponen 
ekstraselular matriks yang lain. Pelbagai rawatan telah dicuba untuk keloid, tetapi secara 
klinikal, kebanyakan terapi masih tidak memuaskan. Kepentingan saintifik tokotrienol 
telah meningkat kerana sifatnya sebagai antioksida dan sifat berkaitan pelindung. Walau 
bagaimanapun, terdapat kekurangan bukti saintifik mengenai keberkesanan tokotrienol 
dalam pengurusan keloid dan parut. Oleh itu, kajian ini telah dijalankan untuk menyiasat 
kesan-kesan berfaedah pecahan tokotrienol (TRF) minyak kelapa sawit pada fibroblas 
keloid. Keloid dan kulit normal dikumpulkan sebagai sampel dalam kajian ini. Fibroblas 
manusia daripada dermis normal dan keloid yang utama telah berjaya dikultur. Penanda 
antibodi protein kejutan haba 47 (HSP47) dan protein permukaan fibroblas (FSP) telah 
digunakan untuk pengesahan fibroblas manusia daripada dermis normal yang utama 
(pNHDF). pNHDF bewarna positif selepas pengeraman dengan antibodi HSP47 dan 
FSP. Untuk membezakan ciri-ciri pertumbuhan antara fibroblas manusia daripada 
dermis normal (nHDF) dan fibroblas daripada keloid (KF), sel hidup nHDF dan KF 
dinilai menggunakan pewarna biru tripan. Kedua-duanya menunjukkan kadar 
 xxii 
pertumbuhan linear tetapi KF yang menunjukkan kadar pertumbuhan yang lebih cepat 
berbanding nHDF. Peratusan sel hidup nHDF dan KF telah diuji dengan 3-(4,5-
Dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) untuk menilai kesan 
toksik dan menindas TRF. Peratusan sel hidup nHDF meningkat secara signifikan 
terhadap masa apabila dirawat dengan kepekatan TRF antara 0.16 µg/ml hingga 19.5 
µg/ml. Keputusan yang bertentangan dilihat apabila nHDF dirawat dengan kepekatan 39 
µg/ml dan 78 µg/ml. Peratusan sel hidup KF menurun terhadap masa apabila dirawat 
dengan semua kepekatan kecuali kepekatan 19.5 µg/ml.  Pada kepekatan 19.5 µg/ml, 
peratusan sel hidup KF meningkat terhadap masa pengeraman. Kepekatan sebanyak 39 
µg/ml secara signifikan menindas pertumbuhan sel-sel KF. Walau bagaimanapun, 
kepekatan TRF tertinggi (78 µg/ml) didapati menjadi toksik kepada kedua-dua nHDF 
dan KF. Teknik mikroatur menggunakan beadchip Illumina HumanRef-8 Expression 
telah digunakan untuk mengenalpasti pengekspresan gen dalam KF terhadap tindak 
balas kepada TRF. Terdapat 906 gen ditemui secara signifikan (p <0.05) berbeza dalam 
pengekspresan dengan perubahan sekurang-kurangnya dua kali ganda dalam KF yang 
dirawat berbanding KF yang tidak dirawat. Pengekspresan 524 gen meningkat dan 
pengekspresan 382 gen menurun dalam KF yang dirawat. Pengekspresan transforming 
growth factor beta  I (TGFβ1), transforming growth factor beta  II (TGFβ2), 
transforming growth factor beta  III (TGFβ3), collagen type III alpha I (COL3A1), 
fibronectin (FN1), transgelin (TAGLN) dan insulin-like growth factor-binding protein 5 
(IGFBP5) telah disahkan menggunakan real-time PCR. Menariknya, TRF didapati 
menurunkan pengekspresan gen tertentu yang biasanya diekspreskan tinggi dalam KF 
seperti gen yang terlibat dalam laluan interaksi ECM-reseptor dan kitaran sel, komponen 
ekstraselular matriks, sitokin yang mendorong fibrosis, pertumbuhan sel dan 
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penyembuhan luka. TRF didapati telah mengubah pengekspresan gen TGFβ2, COL3A1, 
FN1, TAGLN dan IGFBP5 yang tidak normal dalam KF. Hasil kajian mendapati bahawa 
TRF mempunyai kesan bersifat menindas ke atas KF. TRF mempunyai kesan kesihatan 
yang signifikan melalui kesan anti-fibrogenik yang sangat baik ke atas KF berdasarkan 
keupayaan untuk mendorong degradasi ekstraselular matriks dan menghalang 
pembentukan kolagen dan komponen ekstraselular matriks lain yang berlebihan. 
Keputusan ini telah menghasilkan penemuan yang berharga untuk tujuan kosmetik 
kerana berdasarkan profil keselamatan, TRF menjanjikan strategi terapi untuk merawat 
parut keloid atau untuk mencegah pembentukannya.  
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GENE EXPRESSION PROFILE OF PRIMARY FIBROBLASTS FROM 
KELOID AND NORMAL SKIN TREATED WITH PALM OIL TOCOTRIENOL 
RICH FRACTION (TRF) 
 
ABSTRACT 
 
Keloids are dermal fibroproliferative disease that developed due to abnormal wound 
response in predisposed individuals. The alteration of growth factors and cytokines in 
abnormal healing process formed an imbalanced condition between collagen and other 
extracellular matrix components synthesis and degradation. Various treatments for 
keloids have been tried but most of the therapeutic approaches remain clinically 
unsatisfactory. Tocotrienols have gained increasing scientific interest due to their 
antioxidant and related protective properties. However, there is lack of scientific 
evidence regarding the efficacy and therapies of tocotrienol in keloid and scar 
management. Thus, this study was carried out to investigate the effects of palm oil 
tocotrienol rich fraction (TRF) on human keloid fibroblasts. Keloids and normal skin 
were collected as samples in this study. Primary human dermal fibroblast from normal 
skin and keloid tissues were successfully cultured. Heat-shock protein 47 (HSP47) and 
fibroblast surface protein (FSP) antibody markers were used for primary normal human 
dermal fibroblast (pNHDF) verification. pNHDF was positively stained after incubation 
with HSP47 and FSP antibodies. To differentiate growth characteristic between nHDF 
and keloid fibroblast (KF), the cell viability for both cells were assessed using trypan 
blue dye. Both nHDF and KF exhibited linear growth pattern but KF grew faster 
compared to nHDF. The percentage of viable cells of nHDF and KF were assessed by 3-
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(4,5-Dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay in order to 
evaluate cytotoxic and suppressive effects of TRF. The percentage of viable cells of 
nHDF significantly (p <0.05) increased in a time dependent manner when nHDF treated 
with concentrations of TRF at 0.16 µg/ml to 19.5 µg/ml. An opposite result was seen 
when nHDF were treated with TRF at concentrations of 39 µg/ml and 78 µg/ml. The 
percentage of viable cells of KF decreased in a time dependent manner when KF treated 
with all concentrations except at 19.5 µg/ml. At concentration of 19.5 µg/ml, the 
percentage of viable cells of KF increased over the incubation time. TRF at 
concentration of 39 µg/ml significantly (p <0.01) suppressed KF cells growth. However, 
TRF at highest concentration (78 µg/ml) was found to be cytotoxic to both nHDF and 
KF.  Microarray gene expression using Illumina HumanRef-8 Expression BeadChips 
was used to identify the changes in gene expressions in KF in response to TRF. There 
were 906 genes found to be significantly (p <0.05) differentially expressed with at least 
a 2 fold change in treated KF compared to untreated KF.  524 genes were up-regulated 
and 382 genes were down-regulated in treated KF. The expression of transforming 
growth factor-beta I (TGFβ1), transforming growth factor-beta II (TGFβ2), 
transforming growth factor-beta III (TGFβ3), collagen type III alpha I (COL3A1), 
fibronectin (FN1), transgelin (TAGLN) and insulin-like growth factor-binding protein 5 
(IGFBP5) was validated using real-time PCR. Interestingly, TRF down regulates the 
expression of certain genes that are commonly highly expressed in KF such as genes that 
are involved in ECM-receptor interaction and cell cycle pathways, ECM components, 
fibrosis-inducing cytokines, cell growth and wound healing. TRF appeared to reverse the 
abnormal expression of TGFβ2, COL3A1, FN1, TAGLN and IGFBP5 genes in KF. The 
findings of this study concluded that TRF has a suppressive effect on KF. These 
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indicated that TRF have a significant health promoting effects through its excellent anti-
fibrogenic effect on KF based on its ability to induce ECM degradation and inhibit the 
overproduction of collagen and other ECM components. These results provide valuable 
finding for cosmetic reasons because considering its safety profile, TRF represents a 
promising therapeutic strategy to treat keloid scarring or to prevent its development.  
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CHAPTER 1 
 
 
 
INTRODUCTION 
 
 
1.1 Human Skin 
 
1.1.1 Structure of the human skin 
 
The integumentary system is one of the major human body systems that consist of the 
skin, hair, nails, subcutaneous tissue and assorted glands. It has multiple roles including 
in homeostasis, protection, temperature regulation, sensory reception, biochemical 
synthesis and absorption. All the body systems work in an interconnected way with each 
other to maintain the internal conditions of the body thus making it to function properly 
(Farabee, 2010).  
 
Skin is an organ of the integumentary system made up of a layer of tissues that cover the 
underlying muscles and organs. It is the largest organ of the body, making up about 8% 
of the body weight with surface area about 1.6 m
2
 (Igarashi et al., 2005). Although 
structurally consistent throughout the body, the skin thickness is varies depending on the 
person‟s age, gender and area of the body. The variation of skin thickness due to 
variation in collagen and elastin levels. Women have less thick skin than men because 
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skin collagen decreased with age and was less in females at all ages. (Shuster et al., 
1975). This feature make it a unique organ compared to the others. 
 
The complex structures of the skin are shown in Figure 1.1. The multi-layered structure 
of the skin is made up by the different cells, fibers and other components and each of 
them has different functions. The outermost layer of the skin is epidermis which serves 
as the physical and chemical barrier between the interior body and exterior environment. 
The middle layer is known as dermis which provides the structural support of the skin 
and the innermost layer is the subcutaneous tissue. Veins, capillaries and nerves form 
vast networks inside this structure and hairs stick out from the inside of skin. Numerous 
fine hair are scattered over the surface of skin (Igarashi et al., 2005).  
 
 
 
 
 
 
 
 
 
 
 
 3 
 
Figure 1.1: Schematic diagram of the skin. Complex structure of the skin that consists 
of many components to perform a wide variety of functions Adapted from 
(http://www.daviddarling.info/encyclopedia/S/skin.html). 
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The epidermis is a complex multiple layered membrane and the thickness varies over the 
whole body surface in different individuals. It is divided into five sublayers which from 
the bottom are stratum basale, stratum spinosum, stratum granulosum, stratum lucidum 
and stratum corneum (Poirier, 2003). The epidermis contains no veins and capillary. 
Keratinocytes are the main type of cells which make up the epidermis. This cell 
produces keratin which contributes to the rigidity of the outermost layer of skin. It also 
protects the body from the external environment and maintains skin moisture. The other 
epidermal cells are melanocytes which produce the melanin pigment for the purpose of 
ultraviolet protection (Igarashi et al., 2005).  
 
The dermis is the layer beneath the epidermis. This layer is much thicker than the 
epidermis layer, ranging from 1 to 4 mm (Anderson and Parrish, 1982). Dermis consists 
of two layers which are papillary and reticular layer. It contains blood vessels, nerves, 
hair follicles, smooth muscle, glands and lymphatic tissue (Poirier, 2003). The dermis is 
made up of fibroblasts, which produce collagen, elastin and proteoglycans, together with 
mast cells and macrophages (Abdul Majid, 2007). Collagen fibers give the dermis 
strength and toughness while elastin maintains elasticity and flexibility of the dermis 
(Igarashi et al., 2005). The other component such as proteoglycans provides viscosity 
and hydration.  
 
Subcutis, also known as hypodermis is the third layer beneath the dermis. It is an elastic 
layer and contains a large amount of adipose tissue that functions as a shock absorber for 
blood vessels and nerve endings. The thickness of this layer ranged from 4 to 9 mm and 
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it differs between individuals and also depends on the body region (Igarashi et al., 
2005). 
 
1.1.2 Functions of the human skin 
 
The skin not only gives us our appearance and shape but it is an organ in direct contact 
with the environment. It is designed to adapt to stress and strain and protect the fragile 
systems within the body (Slemp and Kirschner, 2006). The primary function of the skin 
is as a protective barrier in preventing the internal tissues from physical trauma, 
ultraviolet (UV) radiation, temperature changes, chemical and pathogens (Butcher and 
White, 2005). Besides preventing harmful substances from entering the body, it also 
controls the loss of vital substances (Graham-Brown and Burns, 1998).  
 
The other function of skin is as organ of sensation. It contains an extensive network of 
nerve cells that allow the body to detect any changes in the environment. There are 
separate receptors for heat, cold, touch and pain. These receptors allow the body to 
detect pain and changes in temperature, touch and pressure. Damage to these nerve cells 
results in a loss of sensation in the affected areas (Timmons, 2006).  
 
Due to the rich capillary network and sweat glands, skin plays an important role in 
regulating heat loss from the body surface. It allows the body to respond to any changes 
in temperature by constricting or dilating the blood vessels (Abdul Majid, 2007). 
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Skin also functions as an organ of excretion. The waste products excreted by sweat 
contain water, urea and albumin. An oily substance known as sebum oil is excreted by 
the sebaceous glands, helping to lubricate and protect the skin (Timmons, 2006). Besides 
acting as a physical barrier, skin also plays an important immunological role. It contains 
all the elements of cellular immunity (Abdul Majid, 2007). It also synthesizes vitamin D 
which is required for calcium absorption. The skin needs to be maintained intact to allow 
the body to perform these vital functions. When it is injured, it rapidly repairs itself in 
order to maintain these external defense systems (Timmons, 2006). 
 
1.2 Wound healing 
 
1.2.1 Mechanism and genes involved in wound healing 
 
The term „wound‟ has been defined as a break in the epithelial integrity of the skin and 
accompanied by disruption of normal anatomical structure and function. Healing is 
defined as the complex and dynamic process that results in the restoration of anatomical 
continuity and function (Lazarus et al., 1994). Wound healing is the body's natural 
process that involves the interaction of a complex cascade of cellular events that 
generates resurfacing, reconstitution and restoration of the tensile strength of wounded 
skin (Romo et al., 2010). 
 
Wound healing process involves changes in expression of specific genes at a specific 
phase of wound healing. However, an aberrant regulation of specific genes plays a key 
role in abnormal healing process (Shilo et al., 2007). This process also involves a variety 
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of cells, cytokine mediators and extracellular matrix (ECM) components which need to 
interact continuosly towards tissue repair (MacKay and Miller, 2003). The normal 
healing response begins at the moment the tissue is injured. This process occurs in 
recognisable, usually progressively through the overlapping phases which are 
hemostasis, inflammatory, proliferation and remodeling phases (Figure 1.2) (Enoch et 
al., 2006).  
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Figure 1.2: Schematic diagram for the four phases of wound healing process. Adapted 
from (Enoch et al., 2006). 
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As the blood spills out, the platelets are attracted to the injury site and come into contact 
with exposed collagen and other elements of the ECM. Platelets are triggered to release 
the clotting factors as well as essential growth factors and cytokines (Diegelmann and 
Evans, 2004). This results in initial vasoconstriction that reduces blood flow through the 
damaged vessels. Generally, hemostasis occurs within minutes of the initial injury unless 
there are underlying clotting disorders (Timmons, 2006). 
 
The expression of pro-inflammatory genes was increased at early phase of wounding. 
These genes involved in tumor necrosis factor (TNF) activation (TNF receptor 
associated factor 1 and 2) and interferon (IFN) activation. The expression of several 
macrophage markers (CD163, Fc-gamma receptor 1 (FcγRI), macrophage scavenger 
receptor 1 and major histocompatibility complex (MHC) class II α chain), T cells 
markers (RAB7L1, and RAB18), B cells (immunoglobulin heavy chain), neutrophils 
(cytochrome b-245), β2 integrin and CD18 were also increased (Kavita et al., 2007).  
 
In early inflammatory phase, the neutrophils enter the wound site and remove the 
foreign materials, bacteria and damaged tissue through phagocytosis. In the late 
inflammatory phase, monocytes are converted to macrophages and phagocytose the 
debris and pathogens (MacKay and Miller, 2003). Macrophages secrete the collagenase 
and elastase which break down injured tissue and release cytokines (Timmons, 2006). In 
addition, it also secretes a variety of chemotactic and growth factors that stimulate cell 
migration, proliferation and formation of the tissue matrix (MacKay and Miller, 2003). 
At the inflammatory phase of wound healing, platelet derived growth factor (PDGF) 
upregulates the expression of Syndecan-4 (SDC4) in fibroblasts. SDC4 interacts with 
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integrins in response to fibronectin and modulates cell adhesion, migration and 
proliferation (Szabad, 2010). 
  
Fibroplasia, angiogenesis and epithelialization are three major processes in proliferative 
phase. Its duration dependent on the size of the wound. The formation of granulation 
tissue is a central event during this phase (Romo et al., 2010). Progranulin promotes 
tissue granulation (He et al., 2003). It activates extracellular kinases. During wound 
healing, progranulin are up-regulated in the dermis for at least 10 days following the 
wound. The expression of progranulin causes neutrophil infiltration and increases the 
accumulation of fibroblasts and blood vessels in the wound by promoting dermal 
fibroblast and endothelial cell proliferation and their migration to type I collagen (He 
and Bateman, 2003). Platelets and macrophages release the chemotactic and growth 
factors which stimulate the migration and activation of fibroblasts.  Fibroblasts play an 
important role in this phase whereas it produces a variety of substances essential to 
wound repair, including collagen, fibronectin, glycosaminoglycans and proteoglycans 
(MacKay and Miller, 2003). The expression of methallothioneins was increased in 
metabolically active and proliferating cells of the dermis. The levels of 
methallothioneins were increased in the wound margin as mitotic activity was increased. 
It is thought to promote cell proliferation and re-epithelialization through its zinc and 
copper binding properties (Lansdown, 2002). During wound healing, fibroblasts express 
connective tissue growth factor (CCN2) which promotes matrix deposition, fibrobast 
proliferation and fibroblast adhesion (Kavita et al., 2007).  
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New blood vessels are formed to deliver oxygen and nutrients to the healing tissues 
(Timmons, 2006). Signal transducer and activator of transcription 3 (Stat3) plays an 
important role in normal wound healing and response to injury. Activation of Stat3 
resulting in upregulation of genes involved in cell invasion, chemotaxis, angiogenesis, 
blood coagulation and remodeling of extracellular matrix. These genes are 
chemoattractants family such as chemokine (C-C motif) ligand 2 (CCL2) and chemokine 
(C-X-C motif) ligand 2 (CXCL2), proteases, SERPIN families such as urokinase 
plasminogen activator (uPA) and its receptor uPAR, coagulation proteins such as 
fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and thrombomodulin, genes 
involved in angiogenesis including endothelial PAS domain-containing protein 1 
(EPAS1), adrenomedullin, angiopoietin-like protein 4 and vascular endothelial growth 
factor (VEGF) (Daniel et al., 2005). 
 
Cysteine protease and cathepsin S present during tissue repair to induce angiogenesis 
(Wang et al., 2006). MMP-9 is a metalloproteinase which promotes angiogenesis 
indirectly by making VEGF more available to its receptor (Bergers et al., 2000). Dermal 
wound repair models demonstrated that Neuropilin-1 (NRP1) is a co-receptor of VEGFR 
and is involved in the VEGF-mediated angiogenesis associated with dermal wound 
repair (Szabad, 2010). Integrin αv is important in angiogenesis, fibroblast migration and 
wound closure. Integrin αvβ5 is a receptor for vitronectin and integrin αvβ3 is a receptor 
for both fibronectin and vitronectin (Serini et al., 2006). Fibroblast migration to an 
angiogenic factor CYN61 is mediated by integrin αvβ5. During normal wound healing, 
fibroblasts differentiate into myofibroblasts in granulation tissue where they play a role 
in wound contraction and scar formation (Lygoe et al., 2004).  
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Remodeling is the final phase of wound healing process. The new collagen matrix then 
becomes cross-linked and organized during this phase to increase the tensile strength of 
wound. This process continues up to two years to be complete (MacKay and Miller, 
2003). 
 
The remodeling genes included type IV collagen and collagen modifying enzymes 
(procollagen C-endopeptidase enhancer and procollagen-lysine, 2-oxoglutarate 5- 
dioxygenase) and the integrin β5 (Kavita et al., 2007). Extracellular S100A4 is involved 
with angiogenesis and the remodeling of extracellular matrix (Senolt et al., 2006).  
 
The successful completion of each step in the healing process is dependent on the 
interactions between stimulation and regulation of cytokine, growth factors, fibroblasts 
and other cells that populate the wound. However, for chronic wounds, the healing 
process can be prolonged by factors which may relate to the type of wound and other 
factors (Timmons, 2006).  
 
1.2.2 The role of cytokines and growth factors in wound healing 
 
The multiple steps of healing process involve a large number of regulatory molecules 
including cytokines and growth factors. These molecules exert a series of direct and 
indirect biological activities which might be important for wound healing. However, 
dysregulation in cytokine or growth factor expression alters the normal healing process 
and blocks the production of specific proinflammatory cytokines (Efron and Moldawer, 
2004). 
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Cytokines are group of regulatory proteins that are released from various cell sources 
which binds to cell surface receptors to stimulate a cell response. They play an important 
role in wound healing process (Romo et al., 2010). The different cytokines are expressed 
in wound site at different time periods during the healing process (Matsuoka and 
Grotendorst, 1989, Witte and Barbul, 1997). Tumor necrosis alpha (TNF-α) is released 
by macrophages to induce neutrophil recruitment and maturation (Rumalla and Borah, 
2001, Feiken et al., 1995, Kunkel et al., 1989, Michie et al., 1988). It increased vascular 
permeability and hemostasis and also induce collagen synthesis and degradation 
(Rumalla and Borah, 2001, Feiken et al., 1995, Dinarello and Moldawer, 2001). The 
other cytokine essential in the healing process is interferon- gamma (IFN-γ) which is 
secreted by T lymphocytes. It induces polymorphonuclear leukocytes and macrophage 
activation and cytotoxicity. It also induces tissue remodeling and reduces wound 
contraction by increasing collagenase expression as well as by decreasing collagen 
production and crosslinking (Rumalla and Borah, 2001, Dinarello and Moldawer, 2001). 
 
Interleukins l alpha and beta (IL-1α and IL-1β) have many similar functions with TNF-
α. It activates neutrophils and promotes chemotaxis by inducing the endothelial cells to 
express proinflammatory cytokines (Loppnow et al., 1998, Fong et al., 1989). IL-1 is 
important in the healing process by increasing collagen synthesis as well as keratinocyte 
and fibroblast growth (Sauder et al., 1990).  
 
Interleukin 8 (IL-8) has numerous functions including neutrophil activation, endothelial 
cell adhesion protein expression and keratinocyte maturation and margination (Liechty 
et al., 1998a, Engelhardt et al., 1998, Nanney et al., 1995, Clark, 1993a). The other type 
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of cytokine frequently found in healing process is interleukin six (IL-6) which is 
secreted by fibroblasts, monocytes and polymorphonuclear cells to stimulate fibroblast 
proliferation (Mateo et al., 1994, Saba et al., 1996, Goodman and Stein, 1994, Pajulo et 
al., 1999). In addition, interleukin four (IL-4) plays an important role in normal healing 
process by promoting fibroblast proliferation, proteoglycan synthesis and collagen 
production (Trautmann et al., 2000, Postlethwaite et al., 1992, Wegrowski et al., 1995). 
Interleukin ten (IL-10) is an anti-inflammatory cytokine secreted by T lymphocytes 
which inhibits the production of proinflammatory cytokines such as TNF-α, IL-1 and IL-
6 as well as preventing neutrophil and macrophage infiltration into the wound (Rumalla 
and Borah, 2001, de Waal Malefyt et al., 1991, Sato et al., 1999). 
 
Healing process is also controlled by a variety of different growth factors. Growth 
factors are peptide mediators that act on target cells to influence cell proliferation and 
cellular activity, including migration and protein synthesis (Rumalla and Borah, 2001, 
Steed, 1997). It plays a major role in tissue repair. PDGF has been shown to be 
chemotactic for cells migrating into the wounded skin such as neutrophils, monocytes 
and fibroblasts. It enhances proliferation of fibroblasts and induces collagen and 
proteoglycan synthesis by these cells (Clark, 1993b, Heldin and Westermark, 1999). It 
also has been shown to enhance angiogenesis (Nakamura et al., 1998).  
 
Fibroblast growth factor (FGF) has over 20 isoforms which are secreted by macrophages 
and endothelial cells in the wound involved in angiogenesis and epithelialization. It has 
the ability to stimulate the fibroblast and keratinocyte proliferation and migration (Ono 
et al., 1999, Detillieux et al., 2003, Gerwins et al., 2000, Mustoe et al., 1991, Hebda et 
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al., 1990, Finetti and Farina, 1992, Pierce et al., 1992). Keratinocyte growth factor 
(KGF) is part of FGF family (Xia et al., 1999, Werner et al., 1994b, Werner et al., 
1994a) and importantly involves in epidermal homeostasis by acting as an essential 
regulator for keratinocyte proliferation and maturation (Rumalla and Borah, 2001). 
 
Epidermal growth factor (EGF) plays a role in epithelialization after being secreted by 
keratinocytes (Cohen et al., 1995). It also increases collagenase secretion by fibroblast 
(Rumalla and Borah, 2001). VEGF is an angiogenic factor which is secreted by 
keratinocytes, macrophages and fibroblasts to induce angiogenesis in healing process 
(Taub et al., 2000, Frank et al., 1999, Shweiki et al., 1992, Nissen et al., 1998). 
 
Literature reveals transforming growth factor-beta (TGF-β) to have important 
implications in all phases of healing process. In wound healing, it is mainly produced by 
the platelet, monocyte and fibroblast. Once the TGF-β binds to it receptor, the 
intracellular signaling pathway is activated and carried out by the Smads proteins (Faler 
et al., 2006). 
 
TGF-β plays a vital role in inflammatory phase of healing process by attracting 
inflammatory cells to the wound site and suppressing the production of proteases. In 
proliferative phase, this growth factor stimulates the fibroblast proliferation and 
migration. It also promotes angiogenesis and impacts epithelialization. TGF-β 
transforms fibroblasts into myofibroblasts for wound contraction in maturational phase 
(Faler et al., 2006).  
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The beneficial effect of cytokines and growth factors in healing process are well 
determined. However, abnormal cytokines and growth factors expression can impair the 
normal healing process and associated with excessive scarring.  
 
1.3 Abnormal scarring 
 
1.3.1 Keloids 
 
Healing process ends with the formation of a scar that is mainly composed of collagen 
which restores the functional integrity of the skin. Abnormal scars are formed as a result 
of alteration of wound healing process and may develop due to deep dermal injuries. The 
imbalance between synthesis and degradation of extracellular matrix components such 
as collagen, fibronectin and proteoglycan by fibroblasts lead to keloids and hypertrophic 
scars formation. This scarring not only causes pain, pruritus and contractures but it also 
affects the patient‟s quality of life both physically and psychologically (Gauglitz et al., 
2011a).  
 
Keloids are skin abnormalities that are unique to humans. It is defined as benign dermal 
fibroproliferative tumours that occur due to abnormal wound response in predisposed 
individuals (Seifert and Mrowietz, 2009). The etiology of keloids remain unclear but 
there are several factors which may contribute to keloids formation such as surgery, 
tattoos, bites, vaccination, blunt trauma, burns and lobular piercing (Kakar et al., 2006). 
It also may occur spontaneously (Meenakshi et al., 2005a).  
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This scarring occurs in all races but it is more common in darker pigmented ethnicities 
compared to white people (Child et al., 1999, Shaffer et al., 2002). Higher incidences of 
this scarring has been reported in Asian, Black and Hispanic populations with value of 
4.5 to 16% (Oluwasanmi, 1974). In contrast, only less than 1% of keloids occur in 
Caucasians (Bloom, 1956). Keloids can develop at any age but most of the cases 
reported are between 10 and 30 years old (Shaffer et al., 2002). 
 
Keloids more frequently occur on parts of the body with high concentrations of 
melanocytes such as chest, shoulders, neck, upper back, upper arms and earlobes (Figure 
1.3) as firm nodules which are pruritic and painful (Bayat et al., 2004). This scarring is 
rarely found on the soles of the feet and palms of the hand because the concentration of 
melanocytes is minimal (Kelly, 1988). It is variable in size from a few millimeters in 
diameter to larger areas (Eryilmaz and Uygur, 2010).  
 
Differentiation between keloids and hypertrophic scar can be problematic. However, 
there are some clinical, histological and epidemiological differences can be used to 
distinguish both of these scarring. The clinical and histological differentiation of keloids 
and hypertrophic scars are shown in Table 1.1. 
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Figure 1.3: The appearance of keloid from patients before surgery. Keloid on (a) 
Shoulder, (b) Earlobe.  
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
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Table 1.1: Differences between keloids and hypertrophic scars. Modified from (Ehrlich 
et al., 1994) 
 
 
Keloids 
 
Hypertrophic scars 
  
 Grow continuously and invasively 
beyond the original wound. 
 Remain within the boundaries of the 
original wound. 
 Do not regress spontaneously.  Regress spontaneously. 
 Appear within several months after initial 
scar and gradually proliferate 
indefinitely. 
 Arise within 4 to 8 weeks and grow 
intensely for several months, then 
regress within one year. 
 Commonly occur on the chest, shoulders, 
upper back, earlobes and rarely on the 
sole of the feet and palms of the hand. 
 No predominant anatomical site. 
 Pruritic and painful.  Less pruritic and painful. 
 Disorganized, larger and thicker collagen 
fibers with no nodules and 
myofibroblasts. 
 Fine and well organized collagen 
fibers with nodules and 
myofibroblasts. 
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1.3.2 Gene expression and pathogenesis of keloids 
 
The pathogenesis of keloids still remains unclear. Recently, most of the research has 
focused on the interaction between keloid fibroblasts and ECM components and 
abnormalities of keloid fibroblasts. In addition, several studies have been done to 
investigate the expression of cytokines, growth factors and their signaling pathways in 
keloids (Seifert and Mrowietz, 2009). Microarray studies provide a broad spectrum of 
differentially regulated genes that may play roles in the pathogenesis of disease. 
Literature reported that there was a difference in expression of a broad spectrum of 
wound-healing and fibrosis related genes between normal and keloid fibroblasts (Russell 
et al., 1995, Smith et al., 2008). 
 
The formations of this abnormal scarring are due to genetic, cellular and molecular 
alteration in the orchestrated healing process (Seifert and Mrowietz, 2009). Imbalance 
between ECM synthesis and degradation lead to keloids formation. Keloids are 
characterized by the increasing of its cellularity. This characteristic increased the 
metabolic activity which is reflected by the increased activity of glycolytic enzymes and 
glycoproteins synthesis (Kakar et al., 2006).  
 
Tenascin C is a glycoprotein produced by fibroblasts or myocytes (Mackie et al., 1998, 
Schalkwijk et al., 1991). It expression increases in wound repair, inflammation and 
hyperproliferative skin diseases (Mackie et al., 1998, Lightner, 1994, Dalkowski et al., 
1999). It is strongly expressed in granulation tissue and at wound edges in the dermis. 
However, it return to normal after wound contraction is completed (Mackie et al., 1998). 
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The expression of tenascin C in keloid is increased and TGF-β1 and interleukin 1 β are 
reported to be potent inducers of tenascin C (Shrestha et al., 1996, Pearson et al., 1998, 
Chevalier et al., 1996). 
 
Type-I procollagen, fibronectin and proteoglycan are synthesized more in fibroblasts 
from keloids compared to normal dermal fibroblasts (Luo et al., 2001, Rodland et al., 
1990). Plasmin and plasminogen activator is an important regulator involved in keloid 
formation.  u-PA and tissue-plasminogen activator (t-PA) activate plasminogen to 
plasmin which acts as fibrinolytic and activates procollagenase (Declerk, 1993). Plasmin 
is involved in activating TGF-β from its latency form (Lyons et al., 1990). Plasminogen 
PAI-1 and TIMP-1 are induced by TGF-β. This lead to decrease of plasmin and 
collagenase activity and thus resulting in diminished collagen degradation. The higher 
expression levels of PAI-1 in keloid fibroblasts leads to increase the accumulation of 
collagen and fibrin in this tissue (Tuan et al., 2003, Tuan et al., 1996).  
 
According to Wu et al. (2004), the expression of VEGF is higher in keloid tissues and 
keloid fibroblasts compared to normal skin. VEGF stimulates the expression of PAI-1, 
in keloid fibroblasts (Wu et al., 2004). VEGF may play an important role in keloid 
formation by altering ECM homeostasis and impaired degradation, thus causing 
excessive accumulation of ECM (Seifert and Mrowietz, 2009). Abundant deposition of 
collagen synthesis in keloid tissue is due to increased activity of prolyl hydroxylase 
enzyme (Murray, 1993, Tuan et al., 2003).  
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Matrix metalloproteinases (MMPs) are involved in ECM degradation such as in 
breakdown of type I and III collagen and other types of collagen (Ghahary and Ghaffari, 
2007). However, an imbalance in expression of MMPs has been implicated in dermal 
fibrosis (Ghahary et al., 1996). The expression of MMP-2 is high while MMP-9 is low 
in hypertrophic scars and keloids (Neely et al., 1999). MMP-2 has major effect on 
matrix remodeling in wound healing by degrading denatured collagen, while MMP-9 is 
involved in early wound repair by degrading native types IV and V collagen, elastin and 
fibronectin (Mauviel, 1993, Zhang et al., 1998). 
 
Although TGF-β plays an important role in normal healing process, it also has been 
implicated in a wide variety of fibrotic disorders. TGF-β1 and TGF-β2 are stimulator of 
collagen and proteoglycan synthesis (Szulgit et al., 2002, Kose and Waseem, 2008). In 
contrast, TGF-β3 induced in the later stages of healing process and has been found to 
reduce connective tissue deposition (Bock et al., 2005). A study from Lee et al. (1999) 
found the expression of TGF-β1 and TGF-β2 are increased in keloid fibroblasts 
compared to normal human skin fibroblasts while the expression of TGF-β3 did not 
differ (Lee et al., 1999b).  
 
IL-6 is reported to have an effect on inflammation and fibroblast proliferation in wound 
healing. However, the high levels of IL-6 have been found to play an important role in 
the pathogenesis of fibroproliferative diseases. A study from Hui et al. (2000) found the 
expression of the IL-6 gene is increased in fibroblasts isolated from keloids when 
compared with control fibroblasts (Hui et al., 2000).  
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Gene profiling studies showed there was a significantly increased in expression of 
several IGF-binding protein such as IGFBP5, IGFBP7 and IGFBP2, jagged 1 (JAG1) 
and CTGF and decreased in expression of  several inhibitors of Wnt such as DKK1, 
DKK3 and secreted frizzled-related protein 1 (SFRP1), MMP3 and dermatopontin 
(DPT) in keloid fibroblasts. The expression of the Wnt stimulatory molecules FZD4 and 
DAAM1 was increased in keloid fibroblasts (Smith et al., 2008). Reduced expression of 
several inhibitors of Wnt signaling and increased of the Wnt stimulatory molecules in 
keloid fibroblasts indicates a role of this pathway in the pathogenesis of keloids (Sato, 
2006).  
 
Whole genome gene expression of keloid fibroblasts or tissues using microarray analysis 
have been conducted by several studies (Satish et al., 2006, Seifert et al., 2008, Smith et 
al., 2008, Naitoh et al., 2005, Hu et al., 2006, Chen et al., 2003, Na et al., 2004). The list 
of differentially expressed genes founded by different studies is differed. Table 1.2 
showed the list of most common genes reported to be dysregulated in keloids by various 
studies. It is likely that mutliple genes impart susceptibility to keloid development, with 
different genes contributing to keloid formation in different individuals.  
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Table 1.2: List of common genes reported to be up or down regulated in keloids by 
microarray studies. 
 
Gene Chen 
et al. 
Na 
et al. 
Naitoh 
et al. 
Hu 
et al. 
Satish 
et al. 
Seifert 
et al. 
Smith 
et al. 
A2M +   +    
ACAN   +   +  
ANXA1    +  +  
COL1A1  + +  + +  
COL1A2 +   +    
COL3A1 +       
COL4A2    +  +  
COL5A2 +  + +    
COL15A1   +   +  
C5ORF13   + +    
EGFR    -  -  
FN1 +  +  + +  
HDGF -   -    
HIF-1A    +  +  
IGFBP7    +  + + 
JAG1    +   + 
POSTN   + +    
VCAN   +   +  
KRT19    -   - 
        
        
